This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001
CS-003
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Decipher Genomic Classifier
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
WCET 2024
SUPS 2024
BCAN TT 2024
SNMMI 2024
ASCO 2024
AUA 2024
All Conferences
View All
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
Active surveillance for prostate cancer: An Australian experience - Abstract
May 25, 2012
In situ and intraductal epithelial proliferations of prostate: Definitions and treatment implications. Part 1: Prostatic intraepithelial neoplasia - Abstract
May 25, 2012
Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI - Abstract
May 25, 2012
Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer - Abstract
May 25, 2012
Detecting prostate cancer with MRI - why and how - Abstract
May 25, 2012
Endocrine prevention and treatment of prostate cancer - Abstract
May 25, 2012
Imaging techniques for local recurrence of prostate cancer: For whom, why and how? - Abstract
May 25, 2012
Phase I/II trial of single-fraction high-dose-rate brachytherapy-boosted hypofractionated intensity-modulated radiation therapy for localized adenocarcinoma of the prostate - Abstract
May 25, 2012
AUA 2012 - The association between male pattern baldness and second to fourth finger ratio with prostate cancer - a prospective cohort study - Press Briefing
May 24, 2012
Validation in Spain of the Quality of Life Questionnaire PROSQOLI in patients with advanced prostate cancer - Abstract
May 24, 2012
Healthcare resource use in advanced prostate cancer patients treated with docetaxel - Abstract
May 24, 2012
Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: Report from a Consensus Panel - Abstract
May 24, 2012
Beyond PSA: The next generation of prostate cancer biomarkers - Abstract
May 24, 2012
AUA 2012 - Genetic variants associated with severity of lower urinary tract symptoms and prostate cancer susceptibility - Press Release
May 24, 2012
AUA 2012 - The association between male pattern baldness and second to fourth finger ratio with prostate cancer - a prospective cohort study - Video Lecture
May 23, 2012
AUA 2012 - A closer look at PSA testing and prostate cancer: The screening debate, genetic connection and risk in young men - Press Release
May 23, 2012
AUA 2012 - Perspectives from the AUA - PSA controversy: Do the harms exceed the benefits or the benefits exceed the harms? - Video statement from William J. Catalona, MD
May 23, 2012
No evidence for infection of UK prostate cancer patients with XMRV, BK virus, Trichomonas vaginalis or human papilloma viruses - Abstract
May 23, 2012
Using graded response model for the prediction of prostate cancer risk - Abstract
May 23, 2012
Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer - Abstract
May 23, 2012
Page 1271 of 1417
Start
Prev
1266
1267
1268
1269
1270
1271
1272
1273
1274
1275
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free